Role of uteroferrin in placental iron transport: effect of maternal iron treatment on fetal iron and uteroferrin content and neonatal hemoglobin

Uteroferrin, an Fe-containing, progesterone-induced glycoprotein is involved in maternal to fetal Fe transport in swine. These studies examined the effect of im Fe injection of dam on conceptus and piglet Fe stores. In Exp. I, eight gilts were bred and assigned to either treatment I (no Fe injections) or treatment II (total of 22 mg iron-dextran/kg body weight on d 40, 45, 50, 55 and 60 of gestation) and hysterectomized on d 90 to determine whether Fe injections increased Fe stores in the conceptus. Total Fe in allantoic fluid (P less than .10) as well as uteroferrin concentration (P less than .05) and total uteroferrin (P less than .05) in placentae were greater for gilts in treatment II. In Exp. II, 19 cross-bred sows were bred and assigned to treatments I and II (d 40, 50 and 60 of gestation), as in Exp. I, and treatment III (total of 22 mg iron-dextran/kg body weight on d 90, 100 and 110 of gestation) to determine effects of treatment on hemoglobin (Hb) values of the piglets at 8 +/- 1 h and d 4 postpartum. Piglets from treatment II had higher (P less than .01) Hb at 8 +/- 1 h, but not on d 4 postpartum. Experiment III was a replication of Exp. II except that Hb values were determined at 8 +/- 1 h, d 4 and d 7 postpartum. On d 7, piglets from treatment II had higher (P less than .05) Hb, but differences at 8 +/- 1 h and d 4 were not significant (P greater than .10).(ABSTRACT TRUNCATED AT 250 WORDS)

Copper and the biological evolution

Copper is contained in a number of enzymes and proteins. A remarkable feature is that except for the electron-carrying blue copper proteins (azurin and plastocyanin) and copper-containing cytochrome c oxidase found in some cyanobacteria and some aerobic bacteria, all copper enzymes and proteins are found only in eukaryotes. In the early and middle precambrian period when the stationary oxygen pressure in the atmosphere was quite low, copper existed as either metallic or cuprous sulfides which are very insoluble in aqueous media; thus copper might have been unavailable to organisms. The time when copper became Cu(II) upon rise of the atmospheric oxygen pressure and thus became available to organisms seems to be in the middle of Proteozoic era when first eukaryotic organisms seem to have appeared on earth. Thus copper may be considered to be an indicator element for the atmospheric evolution (switching from anoxygenic to oxygenic) and the evolution of higher organisms (eukaryotes).

Higher order metaphase chromosome structure: evidence for metalloprotein interactions

One level of DNA organization in metaphase chromosomes is brought about by a scaffolding structure that is stabilized by metalloprotein interactions. Fast-sedimenting, histone-depleted structures (4000-7000 S), derived from metaphase chromosomes by extraction of the histones, are dissociated by metal chelators or by thiol reagents. The chromosomal (scaffolding) proteins responsible for constraining the DNA in this fast-sedimenting form are solubilized under the same conditions. Chromosomes isolated in a metal-depleted form, which generate slow-sedimenting, histone-depleted structures, can be specifically and reversibly stabilized by Cu2+, but not by Mn2+, Co2+, Zn2+ or Hg2+. Metal-depleted chromosomes can also be stabilized by Ca2+ (at 37 degrees C), but this effect is less specific than that of Cu2+. The scaffolding protein pattern that is reproducibly generated following treatment with Cu2+ is composed primarily of two high molecular weight proteins--Sc1 and Sc2 (170,000 and 135,000 daltons). The identification of this simple protein pattern has depended upon the development of new chromosome isolation methods that are highly effective in eliminating cytoskeletal contamination.

Radioresistance in cells with high content of metallothionein

An endogenous cytoplasmic protein, metallothionein (MT) apparently gave rise to radioresistance in 2 different cell lines. A dose reduction factor of 1.9 was achieved in MT-containing cells. MT accounted for a 3-4 fold increase of total sulfhydryl groups in the resistant cell strains, compared to the non-resistant lines from which they were derived. The protein is rich in cysteine (30%), an amino acid known to give radioprotection when administered exogenously. Glutathione levels and cell-cycle phase distribution showed no marked difference between resistant and corresponding non-resistant cells.

Rat kidney metallothionein induced by injection of Cd-thionein: Changes of chromatographic properties with time and their relation to copper content and kidney dysfunction

Cadmium (Cd)-thionein was injected i.p. into adult rats to try to establish the relation between copper (Cu) content in the kidneys and its effect on the properties of metallothionein induced in the kidneys. Elution profiles of the re-synthesized kidney metallothionein changed with time after injection both on a Sephadex and on a gel permeation column (TSK GEL SW3000). The changes were correlated with Cu content in the kidneys caused by kidney dysfunction upon injection of Cd-thionein.

On the role of metallothionein in cadmium absorption by rat jejunum in situ

The role of metallothionein (MT) in the mechanism of cadmium absorption from the jejunum was studied in 7--9 week-old-male rats exposed to 50 ppm of cadmium in drinking water for 9 days. Exposed animals contained an average of 144 micrograms MT/g of mucosal tissue, compared to 40 micrograms in control anaimls. During jejunal perfusion in situ with 5 mM glucose-saline containing 10--20 nM CdCl2 the increased MT content of mucosa exerted no effect either on cadmium absorption from the lumen (step I), or on its further transport into the body (step II). Immediately after perfusion, essentially all cadmium removed from the lumen was fully recovered in the intestinal mucosa. About 50% of the mucosal cadmium was found in the sediment after homogenization and centrifugation; a large portion of this cadmium may be assigned to the membrane fraction. The binding of freshly absorbed cadmium in the mucosal cytosol was not restricted to low molecular weight protein, although cadmium binding capacity in the MT fraction of controls as well as of exposed animals greatly exceeded actual binding of newly absorbed cadmium. Our results offer no support for the view that MT in the jejunal mucosa serves as determinant of cadmium absorption.

Interactions between iron metabolism and oxygen activation

On account of its easy access in aqueous solution to the two states ferrous (FeII) and ferric (FeIII), iron is ideally suited for the activation of molecular oxygen. It is, therefore, logical to seek links between the normal and pathological metabolism of iron and oxygen activation. The pathways of intracellular iron metabolism require changes in the oxidation state of iron both in its deposition in the storage form, ferritin, and in its mobilization from the storage form and use in the cell. Evidence is presented which shows that iron oxidation and deposition in ferritin involves activation of molecular oxygen with formation of a stable peroxo-complex as an intermediate in which the oxygen is bound between two iron atoms attached to adjacent polypeptide chains. The release of iron from ferritin is thought to involve reduction by a flavin, which is associated with the protein, and serves as a cofactor being alternately reduced by NADH or NADPH and oxidized by iron(III). The nature of the low-molecular-weight iron complex which serves to transfer storage iron to transferrin and to supply iron for intracellular use remains to be established. The consequence of excessive iron overload can be rationalized on the basis of oxidative free-radical reactions which provoke lesions typical of deregulated oxygen activation. In some cases these pathological defects can be reversed by iron chelators. Progress in the development of chelation therapy for iron overload are reviewed.

Biliary excretion of cadmium in rat. II. The role of metallothionein in the hepatobiliary transport of cadmium

Intravenous injection of 109Cd-labeled CdCl2 (1 mg/kg) to control rats and rats that had been injected with CdCl2 (0.25 mg/kg) 24 hr earlier showed that there was a decrease in the biliary excretion of 109Cd in the latter group. The 24 hr pretreatment with CdCl2 resulted in induced synthesis of metallothionein in rat liver and kidney. The binding of cadmium to liver tissue was increased and the renal accumulation of cadmium was unaltered on cadmium pretreatment. Rat liver metallothionein was isolated from rats injected repeatedly with CdCl2. Intravenous injection of cadmium-bound metallothionein gave a different distribution of cadmium in the tissues and biological fluids as compared to injection of CdCl2. A major percentage of cadmium was deposited in the kidney with urinary excretion after injection of rat cadmium-metallothionein to control rats. The biliary excretion of cadmium after cadmium-metallothionein injection was minimal. About 90% of cadmium in the kidney cortex and urine could be recovered as cadmium-thionein in sephadex gel filtration, 3 hr after cadmium-thionein injection.

Metallothionein and its relationship to the metabolism of dietary zinc in rats

Metallothionein (MTN), a low molecular weight cytoplasmic metalloprotein has previously been implicated in the metabolism of Zn. Experiments were conducted with rats to determine the effect of feeding varying levels of dietary Zn for short periods on the increase or decrease in MTN-bound Zn. The results indicated that MTN-Zn in both liver and intestinal mucosal cytosol responded rapidly to an altered dietary Zn level and that serum Zn was directly related to the appearance of MTN. 65Zn absorption also responded rapidly to a change in dietary Zn and was inversely correlated with intestinal mucosal MTN-Zn. Hepatic 65Zn uptake appeared to be directly correlated with liver MTN-Zn. A 24 hour fast increased MTN-Zn in rats fed two different levels of Zn except in those rats that were previously treated with actinomycin D. The antibiotic, which blocks DNA-dependent RNA synthesis, appeared to block Zn uptake from blood to the liver. These findings offer support for the involvement of MTN in zinc metabolism.